PuSH - Publikationsserver des Helmholtz Zentrums München

Vouk, K.* ; Hevir, N.* ; Ribič-Pucelj, M.* ; Haarpaintner, G.* ; Scherb, H. ; Osredkar, J.* ; Möller, G. ; Prehn, C. ; Rizner, T.L.* ; Adamski, J.

Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis.

Hum. Reprod. 27, 2955-2965 (2012)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
BACKGROUNDCurrent non-invasive diagnostic methods for endometriosis lack sensitivity and specificity. In search for new diagnostic biomarkers for ovarian endometriosis, we used a hypothesis-generating targeted metabolomics approach.METHODSIn a case-control study, we collected plasma of study participants and analysed their metabolic profiles. We selected a group of 40 patients with ovarian endometriosis who underwent laparoscopic surgery and a control group of 52 healthy women who underwent sterilization at the University Clinical Centre Ljubljana, Slovenia. Over 140 targeted analytes included glycerophospholipids, sphingolipids and acylcarnitines. The analytes were quantified by electrospray ionization tandem mass spectrometry. For assessing the strength of association between the metabolite or metabolite ratios and the disease, we used crude and adjusted odds ratios. A stepwise logistic regression procedure was used for selecting the best combination of biomarkers.RESULTSEight lipid metabolites were identified as endometriosis-associated biomarkers due to elevated levels in patients compared with controls. A model containing hydroxysphingomyelin SMOH C16:1 and the ratio between phosphatidylcholine PCaa C36:2 to ether-phospholipid PCae C34:2, adjusted for the effect of age and the BMI, resulted in a sensitivity of 90.0%, a specificity of 84.3% and a ratio of the positive likelihood ratio to the negative likelihood ratio of 48.3.CONCLUSIONSOur results suggest that endometriosis is associated with elevated levels of sphingomyelins and phosphatidylcholines, which might contribute to the suppression of apoptosis and affect lipid-associated signalling pathways. Our findings suggest novel potential routes for therapy by specifically blocking highly up-regulated isoforms of phosphpolipase A2 and lysophosphatidylcholine acyltransferase 4.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter sphingomyeline; phosphatidylcholine; ether phospholipid; acylcarnitine; ovarian endometriosis; Platelet-Activating-Factor; Human Metabolome; Expression; Apoptosis; Women; Cells; Diglycerides; Neutrophils; Choline; Profile
ISSN (print) / ISBN 0268-1161
e-ISSN 1460-2350
Zeitschrift Human Reproduction
Quellenangaben Band: 27, Heft: 10, Seiten: 2955-2965 Artikelnummer: , Supplement: ,
Verlag Oxford University Press
Begutachtungsstatus Peer reviewed
Institut(e) Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Biomathematics and Biometry (IBB)